{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:28:48Z","timestamp":1791156528944,"version":"4.1.0"},"reference-count":36,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"abstract":"<jats:p>Objective. Recommendations to prevent vertical transmission of group B Streptococcus (GBS) infections have resulted in many women's receiving antibiotics during labor with an associated reduction in early-onset GBS infections in their newborn infants. However, a potential relationship of intrapartum antibiotics (IPA) to the occurrence of late-onset (7\u201390 days) serious bacterial infections (SBIs) in term infants has not been reported. The objectives of this study were to determine whether infants with late-onset SBI were more likely than healthy control infants to have been exposed to IPA and whether there was a greater likelihood of antibiotic resistance in bacteria that were isolated from infants who had an SBI and had been exposed to IPA compared with those who had not.<\/jats:p><jats:p>Methods. We used a case-control design to study the first objective. Cases were previously healthy full-term infants who were hospitalized for late-onset SBI between the ages of 7 and 90 days. Control subjects were healthy full-term infants who were known not to have an SBI in their first 90 days. Cases and control subjects were matched for hospital of delivery. In the second part of the study, rates of antibiotic resistance of bacteria that were isolated from infected infants were compared for those who had and had not been exposed to IPA.<\/jats:p><jats:p>Results. Ninety case infants and 92 control subjects were studied. Considering all types of IPA, more case (41%) than control infants (27%) had been exposed to IPA (adjusted odds ratio [OR]: 1.96; 95% confidence interval [CI]: 1.05\u20133.66), after controlling for hospital of delivery. The association was stronger when IPA was with broad-spectrum antibiotics (adjusted OR: 4.95; 95% CI: 2.04\u201311.98), after controlling for hospital of delivery, penicillin IPA, maternal chorioamnionitis, and breastfeeding. Bacteria that were isolated from infected infants who had been exposed to IPA were more likely to exhibit ampicillin resistance (adjusted OR: 5.7; 95% CI: 2.3\u201314.3), after controlling for hospital of delivery, but not to other antibiotics that are commonly used to treat SBI in infants.<\/jats:p><jats:p>Conclusions. After adjusting for potential confounders, infants with late-onset SBI were more likely to have been exposed to IPA than noninfected control infants. Pathogens that cause late-onset SBI were more likely to be resistant to ampicillin when the infant had been exposed to intrapartum antibiotics.<\/jats:p>","DOI":"10.1542\/peds.2004-2421","type":"journal-article","created":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:36:02Z","timestamp":1125534962000},"page":"696-702","source":"Crossref","is-referenced-by-count":77,"title":["Association of Intrapartum Antibiotic Exposure and Late-Onset Serious Bacterial Infections in Infants"],"prefix":"10.1542","volume":"116","author":[{"given":"Tiffany S.","family":"Glasgow","sequence":"first","affiliation":[{"name":"Divisions of General Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Young","sequence":"additional","affiliation":[{"name":"Divisions of General Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Wallin","sequence":"additional","affiliation":[{"name":"Divisions of General Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Kwok","sequence":"additional","affiliation":[{"name":"Divisions of General Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Stoddard","sequence":"additional","affiliation":[{"name":"Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Firth","sequence":"additional","affiliation":[{"name":"Divisions of General Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Samore","sequence":"additional","affiliation":[{"name":"Internal Medicine"},{"name":"Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie L.","family":"Byington","sequence":"additional","affiliation":[{"name":"Divisions of General Pediatrics"},{"name":"Pediatric Infectious Diseases, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2005,9,1]]},"reference":[{"key":"2021120820022901300_R1","unstructured":"Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep.51:1\u201322, 2002"},{"key":"2021120820022901300_R2","doi-asserted-by":"crossref","unstructured":"Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Pediatrics.\u20081997;99:489\u2013496","DOI":"10.1542\/peds.99.3.489"},{"key":"2021120820022901300_R3","doi-asserted-by":"crossref","unstructured":"Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med.\u20082000;342:15\u201320","DOI":"10.1056\/NEJM200001063420103"},{"key":"2021120820022901300_R4","doi-asserted-by":"crossref","unstructured":"Friedman S, Shah V, Ohlsson A, Matlow AG. Neonatal Escherichia coli infections: concerns regarding resistance to current therapy. Acta Paediatr.\u20082000;89:686\u2013689","DOI":"10.1111\/j.1651-2227.2000.tb00365.x"},{"key":"2021120820022901300_R5","doi-asserted-by":"crossref","unstructured":"Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics.\u20082002;110:690\u2013695","DOI":"10.1542\/peds.110.4.690"},{"key":"2021120820022901300_R6","doi-asserted-by":"crossref","unstructured":"Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med.\u20082002;347:240\u2013247","DOI":"10.1056\/NEJMoa012657"},{"key":"2021120820022901300_R7","doi-asserted-by":"crossref","unstructured":"Shah SS, Ehrenkranz RA, Gallagher PG. Increasing incidence of gram-negative rod bacteremia in a newborn intensive care unit. Pediatr Infect Dis J.\u20081999;18:591\u2013595","DOI":"10.1097\/00006454-199907000-00005"},{"key":"2021120820022901300_R8","doi-asserted-by":"crossref","unstructured":"Towers CV, Carr MH, Padilla G, Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol.\u20081998;179:879\u2013883","DOI":"10.1016\/S0002-9378(98)70182-6"},{"key":"2021120820022901300_R9","doi-asserted-by":"crossref","unstructured":"Towers CV, Briggs GG. Antepartum use of antibiotics and early-onset neonatal sepsis: the next 4 years. Am J Obstet Gynecol.\u20082002;187:495\u2013500","DOI":"10.1067\/mob.2002.124277"},{"key":"2021120820022901300_R10","doi-asserted-by":"crossref","unstructured":"Mercer BM, Carr TL, Beazley DD, Crouse DT, Sibai BM. Antibiotic use in pregnancy and drug-resistant infant sepsis. Am J Obstet Gynecol.\u20081999;181:816\u2013821","DOI":"10.1016\/S0002-9378(99)70307-8"},{"key":"2021120820022901300_R11","doi-asserted-by":"crossref","unstructured":"Terrone DA, Rinehart BK, Einstein MH, Britt LB, Martin JN Jr, Perry KG. Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration. Am J Obstet Gynecol.\u20081999;180:1345\u20131348","DOI":"10.1016\/S0002-9378(99)70017-7"},{"key":"2021120820022901300_R12","doi-asserted-by":"crossref","unstructured":"Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis.\u20082003;3:201\u2013213","DOI":"10.1016\/S1473-3099(03)00577-2"},{"key":"2021120820022901300_R13","doi-asserted-by":"crossref","unstructured":"Edwards RK, Clark P, Sistrom CL, Duff P. Intrapartum antibiotic prophylaxis 1: relative effects of recommended antibiotics on gram-negative pathogens. Obstet Gynecol.\u20082002;100:534\u2013539","DOI":"10.1097\/00006250-200209000-00021"},{"key":"2021120820022901300_R14","doi-asserted-by":"crossref","unstructured":"Baraff LJ, Oslund SA, Schriger DL, Stephen ML. Probability of bacterial infections in febrile infants less than three months of age: a meta-analysis. Pediatr Infect Dis J.\u20081992;11:257\u2013264","DOI":"10.1097\/00006454-199204000-00001"},{"key":"2021120820022901300_R15","doi-asserted-by":"crossref","unstructured":"Harbarth S, Gundlapalli AV, Stockdale W, Samore MH. Shortage of penicillin G: impact on antibiotic prescribing at a US tertiary care centre. Int J Antimicrob Agents.\u20082003;21:484\u2013487","DOI":"10.1016\/S0924-8579(03)00003-7"},{"key":"2021120820022901300_R16","unstructured":"Newman T. Designing an observational study: cross-sectional and case-control studies. In: Hulley SB, Cummings S, Browner WS, Grady D, Newman TB, eds. Designing Clinical Research. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:107\u2013121"},{"key":"2021120820022901300_R17","doi-asserted-by":"crossref","unstructured":"Byington CL, Rittichier KK, Bassett KE, et al. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens. Pediatrics.\u20082003;111:964\u2013968","DOI":"10.1542\/peds.111.5.964"},{"key":"2021120820022901300_R18","doi-asserted-by":"crossref","unstructured":"Hoberman A, Wald ER, Reynolds EA, Penchansky L, Charron M. Pyuria and bacteriuria in urine specimens obtained by catheter from young children with fever. J Pediatr.\u20081994;124:513\u2013519","DOI":"10.1016\/S0022-3476(05)83127-0"},{"key":"2021120820022901300_R19","unstructured":"(NCCLS) NCoCLS. M7A45-Methods for Dilution and Antimicrobial Susceptibility Testing for Bacteria that Grow Aerobically. In; 2000"},{"key":"2021120820022901300_R20","unstructured":"(NCCLS) NCoCLS. M2-A7-Performance for Antimicrobial Disk-Susceptibility Testing: Approved Standard. In; 2000"},{"key":"2021120820022901300_R21","doi-asserted-by":"crossref","unstructured":"Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr.\u20081999;69:1035S\u20131045S","DOI":"10.1093\/ajcn\/69.5.1035s"},{"key":"2021120820022901300_R22","doi-asserted-by":"crossref","unstructured":"Brook I, Barrett CT, Brinkman CR 3rd, Martin WJ, Finegold SM. Aerobic and anaerobic bacterial flora of the maternal cervix and newborn gastric fluid and conjunctiva: a prospective study. Pediatrics.\u20081979;63:451\u2013455","DOI":"10.1542\/peds.63.3.451"},{"key":"2021120820022901300_R23","doi-asserted-by":"crossref","unstructured":"Finegold SM. Changes in Human Intestinal Flora Related to the Administration of Antimicrobial Agents. 1st ed. Lubbock, TX: Academic Press; 1983","DOI":"10.1016\/B978-0-12-341280-5.50022-7"},{"key":"2021120820022901300_R24","doi-asserted-by":"crossref","unstructured":"Spaetgens R, DeBella K, Ma D, Robertson S, Mucenski M, Davies HD. Perinatal antibiotic usage and changes in colonization and resistance rates of group B streptococcus and other pathogens. Obstet Gynecol.\u20082002;100:525\u2013533","DOI":"10.1097\/00006250-200209000-00020"},{"key":"2021120820022901300_R25","doi-asserted-by":"crossref","unstructured":"Gaya H, Adnitt PI, Turner P. Changes in gut flora after cephalexin treatment. Br Med J.\u20081970;3:624\u2013625","DOI":"10.1136\/bmj.3.5723.624"},{"key":"2021120820022901300_R26","doi-asserted-by":"crossref","unstructured":"Heimdahl A, Kager L, Malmborg AS, Nord CE. Impact of different betalactam antibiotics on the normal human flora, and colonization of the oral cavity, throat and colon. Infection.\u20081982;10:120\u2013124","DOI":"10.1007\/BF01816741"},{"key":"2021120820022901300_R27","doi-asserted-by":"crossref","unstructured":"Heimdahl A, Nord CE. Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scand J Infect Dis.\u20081979;11:233\u2013242","DOI":"10.3109\/inf.1979.11.issue-3.11"},{"key":"2021120820022901300_R28","doi-asserted-by":"crossref","unstructured":"Brunel A, Gouet P. Influence of the destabilisation of the maternal digestive microflora on that of the newborn rat. Biol Neonate.\u20081993;63:236\u2013245","DOI":"10.1159\/000243937"},{"key":"2021120820022901300_R29","doi-asserted-by":"crossref","unstructured":"Bruinsma N, Hutchinson JM, van den Bogaard AE, Giamarellou H, Degener J, Stobberingh EE. Influence of population density on antibiotic resistance. J Antimicrob Chemother.\u20082003;51:385\u2013390","DOI":"10.1093\/jac\/dkg072"},{"key":"2021120820022901300_R30","doi-asserted-by":"crossref","unstructured":"Shea KM. Antibiotic resistance: what is the impact of agricultural uses of antibiotics on children's health?Pediatrics.\u20082003;112:253\u2013258","DOI":"10.1542\/peds.112.S1.253"},{"key":"2021120820022901300_R31","doi-asserted-by":"crossref","unstructured":"Aiello AE, Larson E. Antibacterial cleaning and hygiene products as an emerging risk factor for antibiotic resistance in the community. Lancet Infect Dis.\u20082003;3:501\u2013506","DOI":"10.1016\/S1473-3099(03)00723-0"},{"key":"2021120820022901300_R32","doi-asserted-by":"crossref","unstructured":"Holmes SJ, Morrow AL, Pickering LK. Child-care practices: effects of social change on the epidemiology of infectious diseases and antibiotic resistance. Epidemiol Rev.\u20081996;18:10\u201328","DOI":"10.1093\/oxfordjournals.epirev.a017913"},{"key":"2021120820022901300_R33","doi-asserted-by":"crossref","unstructured":"Spach DH, Black D. Antibiotic resistance in community-acquired respiratory tract infections: current issues. Ann Allergy Asthma Immunol.\u20081998;81:293\u2013302; quiz 302\u2013303","DOI":"10.1016\/S1081-1206(10)63121-3"},{"key":"2021120820022901300_R34","doi-asserted-by":"crossref","unstructured":"Samore MH, Magill MK, Alder SC, et al. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics.\u20082001;108:856\u2013865","DOI":"10.1542\/peds.108.4.856"},{"key":"2021120820022901300_R35","doi-asserted-by":"crossref","unstructured":"Lodise TP Jr, McKinnon PS, Rybak M. Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance. Infect Control Hosp Epidemiol.\u20082003;24:655\u2013661","DOI":"10.1086\/502269"},{"key":"2021120820022901300_R36","doi-asserted-by":"crossref","unstructured":"Finkelstein JA, Huang SS, Daniel J, et al. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics.\u20082003;112:862\u2013869","DOI":"10.1542\/peds.112.4.862"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/3\/696\/1005078\/zpe00905000696.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/3\/696\/1005078\/zpe00905000696.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T09:55:28Z","timestamp":1683194128000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/116\/3\/696\/68375\/Association-of-Intrapartum-Antibiotic-Exposure-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,9,1]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-2421","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,1]]}}}